LABORIE has redesigned its website to include Medical Measurement Systems (MMS) Urology and Gastroenterology products. The newly designed website (www.laborie.com) now features Urology and Gastroenterology product lines and resources from both LABORIE and MMS.
The needs and challenges of its customers are at the core of LABORIE’s new digital experience. This is reflected in the structure of the new website, which was designed to provide a user-first experience with improved navigation and functionality throughout. Users are now able to easily access valuable educational resources and extensive product information across multiple browsers and devices.
As LABORIE continues to grow over the next few months, so will its new digital experience. The LABORIE team is working hard behind the scenes to further expand the information on the website and to build a digital experience that is reflective of LABORIE’s commitment to innovation and growth.
LABORIE (www.laborie.com), headquartered in Toronto, Canada, is a leading global developer, manufacturer and marketer of innovative medical technology and consumables for diagnosis and treatment in Urodynamics and Gastroenterology as well as other pelvic floor disorders.
LABORIE Medical Technologies (“LABORIE”) and Cogentix Medical, Inc. (NASDAQ: CGNT) (“Cogentix”) today announced the completion of the acquisition by LABORIE of Cogentix through LABORIE’S affiliate Camden Merger Sub, Inc. (“Merger Sub”), a wholly owned subsidiary of LM US Parent, Inc. (“Parent”).
LABORIE Medical Technologies (“LABORIE”) announced the successful completion of the tender offer by its affiliate Camden Merger Sub, Inc. (“Merger Sub”), a wholly owned subsidiary of LM US Parent, Inc. (“Parent”) to purchase all outstanding shares of common stock of Cogentix Medical, Inc. (NASDAQ: CGNT) (“Cogentix”)
LABORIE Medical Technologies, a leading global developer and manufacturer of medical diagnostics and devices in the pelvic health and gastroenterology market, today announces the execution of a definitive agreement to acquire Cogentix Medical Inc., (NASDAQ: CGNT)